The DOI matches its Crossref record; 342 of the 342 references it cites were found in a registry or an index.
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
Open accessAbstract
Respiratory viruses infect the human upper respiratory tract, mostly causing mild diseases. However, in vulnerable populations, such as newborns, infants, the elderly and immune-compromised individuals, these opportunistic pathogens can also affect the lower respiratory tract, causing a more severe disease (e.g., pneumonia). Respiratory viruses can also exacerbate asthma and lead to various types of respiratory distress syndromes. Furthermore, as they can adapt fast and cross the species barrier, some of these pathogens, like influenza A and SARS-CoV, have occasionally caused epidemics or pandemics, and were associated with more serious clinical diseases and even mortality. For a few decades now, data reported in the scientific literature has also demonstrated that several respiratory viruses have neuroinvasive capacities, since they can spread from the respiratory tract to the central nervous system (CNS). Viruses infecting human CNS cells could then cause different types of encephalopathy, including encephalitis, and long-term neurological diseases. Like other well-recognized neuroinvasive human viruses, respiratory viruses may damage the CNS as a result of misdirected host immune responses that could be associated with autoimmunity in susceptible individuals (virus-induced neuro-immunopathology) and/or viral replication, which directly causes damage to CNS cells (virus-induced neuropathology). The etiological agent of several neurological disorders remains unidentified. Opportunistic human respiratory pathogens could be associated with the triggering or the exacerbation of these disorders whose etiology remains poorly understood. Herein, we present a global portrait of some of the most prevalent or emerging human respiratory viruses that have been associated with possible pathogenic processes in CNS infection, with a special emphasis on human coronaviruses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinical, post-mortem, animal, in vitro, and cell culture studies demonstrated that coronaviruses are potentially neurotropic and can induce neuronal injuries (Desforges et al., 2019).”
From Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors (2020) · cites this paper as Desforges et al., 2019
In the citing paper
“As a consequence, CoV can enter the brain through the olfactory tract in the early stages of infection or nasal vaccination (Desforges et al., 2019, Mori, 2015).”
From Nervous system involvement after infection with COVID-19 and other coronaviruses (2020) · cites this paper as Desforges et al., 2019
In the citing paper
“Although there is rare evidence that CoV, especially SARS-CoV-2, invade the nervous system via the blood circulation pathway (Koyuncu et al., 2013, Desforges et al., 2019), subsequent studies are expected.”
From Nervous system involvement after infection with COVID-19 and other coronaviruses (2020) · cites this paper as Desforges et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,804
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Tg, K., Erdman, D. D., Cs, G., Zaki, Peret, T. C. T., Emery, S. L., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,353
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910
Nair, H., Nokes, D. J., Gessner, B. D., Dherani, M., Madhi, S. A., Singleton, R. J., O'Brien, K. L., Roca, A., Wright, P. F., Bruce, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60206-1 · Cited by 2,773
Bats Are Natural Reservoirs of SARS-Like Coronaviruses
Li, W., Shi, Z., Yu, M., Ren, W., Smith, C. S., Epstein, J. H., Wang, H., Crameri, G. S., Hú, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,571
Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. M., Dawson, V. L., El-Deiry, W. S., Fulda, S., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.96 · Cited by 2,421
Guan, Y., Zheng, B., He, Y., Liu, X. L., Zhuang, Z. X., Cheung, C. L., Luo, S., Li, P. H., Zhang, L., Guan, Y., et al. (2003) · Science · doi:10.1126/science.1087139 · Cited by 2,404
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 999
Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
Burks, S. M., Rosas-Hernandez, H., Alejandro Ramirez-Lee, M., Cuevas, E., & Talpos, J. C. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.12.031 · Cited by 97
Vonck, K. E. J., Garrez, I., Herdt, V. D., Hemelsoet, D., Laureys, G., Raedt, R., & Boon, P. (2020) · European Journal of Neurology · doi:10.1111/ene.14329 · Cited by 99
Banerjee, D., & Viswanath, B. (2020) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2020.102350 · Cited by 100
COVID‐19 and seizures: Is there a link?
Vohora, D., Jain, S., Tripathi, M., & Potschka, H. (2020) · Epilepsia · doi:10.1111/epi.16656 · Cited by 94
Neuroinflammation: A Signature or a Cause of Epilepsy?
Pracucci, E., Pillai, V., Lamers, D., Parra, R., & Landi, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136981 · Cited by 99
Guillain-Barré Syndrome as a Neurological Complication of Novel COVID-19 Infection
Paybast, S., Gorji, R., & Mavandadi, S. (2020) · The Neurologist · doi:10.1097/nrl.0000000000000291 · Cited by 93
Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects
Varahachalam, S. P., Lahooti, B., Chamaneh, M., Bagchi, S., Chhibber, T., Morris, K., Bolanos, J. F., Kim, N., & Kaushik, A. K. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s283686 · Cited by 95
Zalpoor, H., Akbari, A., Samei, A., Forghaniesfidvajani, R., Kamali, M., Afzalnia, A., Manshouri, S., Heidari, F., Pornour, M., Khoshmirsafa, M., et al. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00311-1 · Cited by 92
Neuropathologic findings of patients with COVID-19: a systematic review
Pajo, A. T., Espiritu, A. I., Apor, A. D. A. O., & Jamora, R. D. G. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05068-7 · Cited by 92
Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2
Iroegbu, J. D., Ifenatuoha, C. W., & Ijomone, O. M. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04469-4 · Cited by 92
Murta, V., Villarreal, A., & Ramos, A. J. (2020) · ASN NEURO · doi:10.1177/1759091420954960 · Cited by 90
Inflammation at the crossroads of COVID-19, cognitive deficits and depression
Silva, N. M. L. E., Barros‐Aragão, F. G. Q., Felice, F. G. D., & Ferreira, S. T. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109023 · Cited by 96
A potential interaction between the SARS-CoV-2 spike protein and nicotinic acetylcholine receptors
Oliveira, A. S. F., Ibarra, A. Á., Bermúdez, I., Casalino, L., Gaieb, Z., Shoemark, D. K., Gallagher, T. C., Sessions, R. B., Amaro, R. E., & Mulholland, A. J. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.01.037 · Cited by 92
Battagello, D. S., Dragunas, G., Klein, M., Ayub, A. L. P., Velloso, F. J., & Correa, R. G. (2020) · Clinical Science · doi:10.1042/cs20200904 · Cited by 88
Wang, Z., Yang, Y., Liang, X., Gao, B., Liu, M., Li, W., Chen, Z., & Wang, Z. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.571996 · Cited by 87
Neurological manifestations of coronavirus infections – a systematic review
Almqvist, J., Granberg, T., Tzortzakakis, A., Klironomos, S., Kollia, E., Öhberg, C., Martinꝉ, R., Piehl, F., Ouellette, R., & Ineichen, B. V. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51166 · Cited by 85
Zamani, R., Pouremamali, R., & Rezaei, N. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2021-0082 · Cited by 80
Wilson, M. P., & Jack, A. S. (2020) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.105866 · Cited by 83
Erythropoietin as candidate for supportive treatment of severe COVID-19
Ehrenreich, H., Weißenborn, K., Begemann, M., Busch, M., Vieta, E., & Miskowiak, K. W. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00186-y · Cited by 98
Neurological Complications of COVID-19: Underlying Mechanisms and Management
Shehata, G. A., Lord, K. C., Grudzinski, M. C., Elsayed, M., Abdelnaby, R., & Elshabrawy, H. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084081 · Cited by 84
Potential neurological effects of severe COVID-19 infection
Nuzzo, D., & Picone, P. (2020) · Neuroscience Research · doi:10.1016/j.neures.2020.06.009 · Cited by 81
Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients
DeKosky, S. T., Kochanek, P. M., Valadka, A. B., Clark, R. S. B., Chou, S., Au, A. K., Horvat, C. M., Jha, R. M., Mannix, R., Wisniewski, S. R., et al. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2020.7332 · Cited by 87
Could SARS‐CoV‐2 affect male fertility?
Vishvkarma, R., & Rajender, S. (2020) · Andrologia · doi:10.1111/and.13712 · Cited by 82
Hawkins, M., Sockalingam, S., Bonato, S., Rajaratnam, T., Ravindran, M., Gosse, P. J., & Sheehan, K. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110350 · Cited by 79
Neurological Manifestations in COVID-19 Patients: A Meta-Analysis
Vitalakumar, D., Sharma, A., Kumar, A., & Flora, S. J. S. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00353 · Cited by 83
Johansson, A., Mohamed, M. S., Moulin, T. C., & Schiöth, H. B. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577658 · Cited by 80
Anxiety and Its Associated Factors During the Initial Phase of the COVID-19 Pandemic in Indonesia
Anindyajati, G., Wiguna, T., Murtani, B. J., Christian, H., Wigantara, N. A., Putra, A. A., Hanafi, E., Minayati, K., Ismail, R. I., Kaligis, F., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.634585 · Cited by 92
Prudencio, M., Erben, Y., Marquez, C. P., Jansen-West, K. R., Franco-Mesa, C., Heckman, M. G., White, L. J., Dunmore, J. A., Cook, C. N., Lilley, M. T., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abi7643 · Cited by 78
Neurological involvement in SARS-CoV-2 infection: A clinical systematic review
Scoppettuolo, P., Borrelli, S., & Naeije, G. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100094 · Cited by 78
Ning, X., Yu, F., Huang, Q., Li, X., Luo, Y., Huang, Q. M., & Chen, C. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02838-z · Cited by 79
Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 DiseasePreprint
Serrano, G. E., Walkera, J., Arce, R., Glass, M. J., Vargas, D., Sue, L. I., Intorcia, A. J., Nelson, C. M., Oliver, J., Papa, J. D., et al. (2021) · medRxiv · doi:10.1101/2021.02.15.21251511 · Cited by 81
Self-citationCOVID-19: dealing with a potential risk factor for chronic neurological disorders
Schirinzi, T., Landi, D., & Liguori, C. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10131-y · Cited by 78
What’s New With the Old Coronaviruses?
Ogimi, C., Kim, Y. J., Martin, E. T., Huh, H. J., Chiu, C., & Englund, J. A. (2020) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piaa037 · Cited by 77
Endothelial cells and SARS-CoV-2: An intimate relationship
Barbosa, L. C., Gonçalves, T. L., de Araújo, L. P., Rosário, L., & Ferrer, V. P. (2021) · Vascular Pharmacology · doi:10.1016/j.vph.2021.106829 · Cited by 78
Potential Neurologic Manifestations of COVID-19
Nordvig, A. S., Rimmer, K., Willey, J. Z., Thakur, K. T., Boehme, A. K., Vargas, W. S., Smith, C. J., & Elkind, M. S. V. (2020) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000897 · Cited by 75
Why do SARS-CoV-2 NSPs rush to the ER?
Santerre, M., Arjona, S. P., Allen, C. N. S., Shcherbik, N., & Sawaya, B. E. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10197-8 · Cited by 75
COVID-19-Induced Psychosis and Suicidal Behavior: Case Report
Chacko, M., Job, A., Caston, F., George, P., Yacoub, A., & Cáceda, R. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00530-7 · Cited by 74
Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients
Ermis, U., Rust, M. I., Bungenberg, J., Costa, A. S., Dreher, M., Balfanz, P., Marx, G., Wiesmann, M., Reetz, K., Tauber, S. C., et al. (2021) · Neurological Research and Practice · doi:10.1186/s42466-021-00116-1 · Cited by 77
SARS-CoV-2: is there neuroinvasion?
McQuaid, C., Brady, M., & Deane, R. (2021) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00267-y · Cited by 72
The Causes and Long-Term Consequences of Viral Encephalitis
Böhmwald, K., Andrade, C. A., Gálvez, N. M. S., Mora, V. P., Muñóz, J. T., & Kalergis, A. M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.755875 · Cited by 73
Study, T. G.-N., Frontera, J. A., Mainali, S., Fink, E. L., Robertson, C., Schober, M. E., Ziai, W., Menon, D. K., Kochanek, P. M., Suárez, J. I., et al. (2020) · Neurocritical Care · doi:10.1007/s12028-020-00995-3 · Cited by 72
Levy, E. H., DELVIN, E. E., Marcil, V., & Spahis, S. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00298.2020 · Cited by 73
Pellinen, J., Carroll, E. E., Friedman, D. J., Boffa, M., Dugan, P. C., Friedman, D. E., Gazzola, D. M., Jongeling, A. C., Rodriguez, A. J., & Holmes, M. (2020) · Epilepsia · doi:10.1111/epi.16667 · Cited by 71
Soltani, S., Tabibzadeh, A., Zakeri, A., Zakeri, A. M., Latifi, T., Shabani, M., Pouremamali, A., Erfani, Y., Pakzad, I., Malekifar, P., et al. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0108 · Cited by 71
Briguglio, M., Bona, A. R., Porta, M., Dell’Osso, B. M., Pregliasco, F. E., & Banfi, G. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00671 · Cited by 70
Meyer, P. T., Hellwig, S., Blazhenets, G., & Hosp, J. A. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.263085 · Cited by 70
Binder, M. D., Mazereel, V., Stroobants, M., Picker, L. D., Assche, K. V., & Detraux, J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.798554 · Cited by 69
Neurological manifestations of COVID-19, SARS and MERS
Verstrepen, K., Baisier, L., & Cauwer, H. D. (2020) · Acta Neurologica Belgica · doi:10.1007/s13760-020-01412-4 · Cited by 68
Presentations and mechanisms of CNS disorders related to COVID-19
Bodro, M., Compta, Y., & Sánchez‐Valle, R. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000923 · Cited by 69
SARS-CoV-2 and the Brain: What Do We Know about the Causality of ‘Cognitive COVID?
Awan, H. A., Diwan, M. N., Aamir, A., Ali, M., Giannantonio, M. D., Ullah, I., Shoib, S., & Berardis, D. D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153441 · Cited by 71
Sarubbo, F., Haji, K. E., Vidal-Balle, A., & Bargay, J. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100399 · Cited by 71
Hu, J., Jolkkonen, J., & Zhao, C. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.012 · Cited by 69
A complication of coronavirus disease 2019: delirium
Cipriani, G., Danti, S., Nuti, A., Carlesi, C., Lucetti, C., & Di Fiorino, M. (2020) · Acta Neurologica Belgica · doi:10.1007/s13760-020-01401-7 · Cited by 65
RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients
Eberhardt, K. A., Meyer‐Schwickerath, C., Heger, E., Knops, E., Lehmann, C., Rybniker, J., Schommers, P., Eichenauer, D. A., Kurth, F., Ramharter, M., et al. (2020) · Viruses · doi:10.3390/v12091045 · Cited by 65
Nicotine and the nicotinic cholinergic system in COVID‐19
Tizabi, Y., Getachew, B., Copeland, R., & Aschner, M. (2020) · FEBS Journal · doi:10.1111/febs.15521 · Cited by 66
Widespread white matter oedema in subacute COVID-19 patients with neurological symptoms
Rau, A., Schroeter, N., Blazhenets, G., Dreßing, A., Walter, L. I., Kellner, E., Bormann, T., Mast, H., Wagner, D., Urbach, H., et al. (2022) · Brain · doi:10.1093/brain/awac045 · Cited by 63
Campos, M. C., Nery, T., Starke, A. C., Alves, A. C. D. B., Speck, A. E., & Aguiar, A. S. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104902 · Cited by 71
Kozak, R. A., Prost, K., Yip, L., Williams, V. L., Leis, J. A., & Mubareka, S. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104338 · Cited by 63
Alexander, S. P. H., Armstrong, J. F., Davenport, A. P., Davies, J. A., Faccenda, E., Harding, S. D., Levi‐Schaffer, F., Maguire, J. J., Pawson, A. J., Southan, C., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15094 · Cited by 61
Report on Electroencephalographic Findings in Critically Ill Patients with COVID ‐19
Vespignani, H., Colas, D., Lavin, B. S., Soufflet, C., Maillard, L. G., Pourcher, V., Paccoud, O., Medjebar, S., & Frouin, P.-Y. (2020) · Annals of Neurology · doi:10.1002/ana.25814 · Cited by 63
Pang, K. W., Chee, J., Subramaniam, S., & Ng, C. L. (2020) · Current Allergy and Asthma Reports · doi:10.1007/s11882-020-00972-y · Cited by 62
Mirtaleb, M. S., Mirtaleb, A. H., Nosrati, H., Heshmatnia, J., Falak, R., & Emameh, R. Z. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111518 · Cited by 64
Han, Y., Yuan, K., Wang, Z., Liu, W., Lu, Z.-A., Liu, L., Shi, L., Yan, W., Yuan, J., Li, J., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01629-8 · Cited by 67
Ogier, M., Andéol, G., Sagui, E., & Bo, G. D. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100081 · Cited by 66
Alam, S. B., Willows, S. D., Kulka, M., & Sandhu, J. K. (2020) · European Journal of Neurology · doi:10.1111/ene.14442 · Cited by 61
COVID-19 Pulmonary and Olfactory Dysfunctions: Is the Chemokine CXCL10 the Common Denominator?
Oliviero, A., de Castro, F., Coperchini, F., Chiovato, L., & Rotondi, M. (2020) · The Neuroscientist · doi:10.1177/1073858420939033 · Cited by 64
Central Nervous System Targets and Routes for SARS-CoV-2: Current Views and New Hypotheses
Barrantes, F. J. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00434 · Cited by 65
SARS-CoV-2, an Underestimated Pathogen of the Nervous System
Jakhmola, S., Indari, O., Chatterjee, S., & Jha, H. C. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00522-7 · Cited by 64
Zhou, J., Liu, C., Sun, Y., Huang, W., & Ye, K. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.10.019 · Cited by 62
Elhadi, M., Alsoufi, A., Abusalama, A., Alkaseek, A. M., Abdeewi, S., Yahya, M., Mohammed, A. A. K., Abdelkabir, M., Huwaysh, M., Amkhatirah, E., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251085 · Cited by 63
on behalf of Italian Society of Neurology (SIN), Ferrarese, C., Silani, V., Priori, A., Galimberti, S., Agostoni, E. C., Monaco, S., Padovani, A., & Tedeschi, G. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04450-1 · Cited by 63
The COVID-19 pandemic and Alzheimer’s disease: mutual risks and mechanisms
Chen, F., Chen, Y., Wang, Y., Ke, Q., & Cui, L. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00316-y · Cited by 63
THE NERVOUS SYSTEM DAMAGE IN COVID-19 PATIENTS
Викторович, Б. В., Samoilova, E. M., & Baklaushev, V. P. (2020) · Journal of clinical practice · doi:10.17816/clinpract34851 · Cited by 89
Neurobiology of COVID-19: how can the virus affect the brain?
Generoso, J. S., de Quevedo, J. L. B., Cattani, M., Lodetti, B. F., Sousa, L., Collodel, A., Díaz, A. P., & Dal‐Pizzol, F. (2021) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-1488 · Cited by 65
SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations
Krishnamoorthy, S., Swain, B., Verma, R. S., & Gunthe, S. S. (2020) · VirusDisease · doi:10.1007/s13337-020-00632-9 · Cited by 63
Delirium as a presenting feature in COVID-19: Neuroinvasive infection or autoimmune encephalopathy?
Hosseini, A. A., Shetty, A. K., Sprigg, N., Auer, D. P., & Constantinescu, C. S. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.06.012 · Cited by 58
Applications of Non-invasive Neuromodulation for the Management of Disorders Related to COVID-19
Baptista, A. F., Baltar, A., Okano, A. H., Moreira, A., Campos, A. C. P., Fernandes, A. M., Brunoni, A. R., Badran, B. W., Tanaka, C., de Andrade, D. C., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.573718 · Cited by 62
Neuropsychiatric manifestations of COVID-19 can be clustered in three distinct symptom categories
Mirfazeli, F. S., Sarabi‐Jamab, A., Jahanbakhshi, A., Kordi, A., Javadnia, P., Shariat, S. V., Aloosh, O., Almasi‐Dooghaee, M., & Faiz, S. H. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-78050-6 · Cited by 60
Kumar, D., Jahan, S., Khan, A., Siddiqui, A. J., Redhu, N. S., Wahajuddin, M., Khan, J., Banawas, S., Alshehri, B., & Alaidarous, M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02318-9 · Cited by 60
Severe loss of mechanical efficiency in COVID‐19 patients
Pleguezuelos, E., Carmen, A. D., Llorensi, G., Carcole, J., Casarramona, P., Moreno, E., Ortega, P., Serra-Prat, M., Palomera, E., Miravitlles, M., et al. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12739 · Cited by 58
Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
Uversky, V. N., Elrashdy, F., Aljaddawi, A. A., Ali, S. M., Khan, R. H., & Redwan, E. M. M. M. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24752 · Cited by 59
Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models
Liu, H.-L., Yeh, I., Phan, N. N., Wu, Y., Yen, M., Hung, J., Chiao, C.-C., Chen, C., Sun, Z., Jiang, J., et al. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104438 · Cited by 56
Electrochemical sensing: A prognostic tool in the fight against COVID-19
Kotru, S., Klimuntowski, M., Ridha, H., Uddin, Z., Askhar, A. A., Singh, G., & Howlader, M. M. R. (2021) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2021.116198 · Cited by 57
SARS-CoV-2 involvement in central nervous system tissue damage
Sabra, M., Kobeissy, F. H., Bizri, M., Haidar, M. A., Shakkour, Z., Reslan, M. A., Al-Haj, N., Chamoun, P., Habashy, K. J., Kaafarani, H., et al. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.327323 · Cited by 58
COVID-19, Oxidative Stress, and Neuroinflammation in the Depression Route
Mingoti, M. E. D., Bertollo, A. G., Simões, J. L. B., Francisco, G. R., Bagatini, M. D., & Ignácio, Z. M. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02004-y · Cited by 60
Neurological Involvements of SARS-CoV2 Infection
Gasmi, A., Tippairote, T., Mujawdiya, P. K., Benahmed, A. G., Menzel, A., Dadar, M., & Bjørklund, G. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02070-6 · Cited by 62
Chougar, L., Mathon, B., Weiss, N., Degos, V., & Shor, N. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6642 · Cited by 55
Emerging zoonotic viral infections of occupational health importance
Vonesch, N., Binazzi, A., Bonafede, M., Melis, P. M., Ruggieri, A., Iavicoli, S., & Tomao, P. (2019) · Pathogens and Disease · doi:10.1093/femspd/ftz018 · Cited by 54
Dedoncker, J., Vanderhasselt, M., Ottaviani, C., & Slavich, G. M. (2021) · Neuroscience and Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.010 · Cited by 49
TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2
Kaushik, D., Bhandari, R., & Kuhad, A. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1918103 · Cited by 59
Pereira, A. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00308 · Cited by 55
Involvement of the nervous system in COVID-19: The bell should toll in the brain
Satarker, S., & Nampoothiri, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118568 · Cited by 53
Eser, H. Y., Köroğlu, Y. E., Çakmak, Ö. Ö., Keskin, Ö., Gürsoy, A., & Özdemir, Y. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.656313 · Cited by 55
Postolache, T. T., Benros, M. E., & Brenner, L. A. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.2795 · Cited by 53
Neurologic complications of COVID-19
Hassett, C. E., Gedansky, A., Migdady, I., Bhimraj, A., Uchino, K., & Cho, S. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.ccc058 · Cited by 55
Borah, P., Deb, P. K., Chandrasekaran, B., Goyal, M., Bansal, M., Hussain, S., Shinu, P., Venugopala, K. N., Al‐Shar’i, N. A., Deka, S., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.627723 · Cited by 53
How to carry out and interpret EEG recordings in COVID-19 patients in ICU?
Gélisse, P., Rossetti, A. O., Genton, P., Crespel, A., & Kaplan, P. W. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2020.05.006 · Cited by 52
COVID-19: Molecular and Cellular Response
Alipoor, S. D., Mortaz, E., Jamaati, H., Tabarsi, P., Bayram, H., Varahram, M., & Adcock, I. M. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.563085 · Cited by 53
Neurological complications associated with Covid‐19; molecular mechanisms and therapeutic approaches
Mehrabani, M. M., Karvandi, M. S., Maafi, P., & Doroudian, M. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2334 · Cited by 53
Respiratory syncytial virus tropism for olfactory sensory neurons in mice
Bryche, B., Frétaud, M., Deliot, A. S.-A., Galloux, M., Sedano, L., Langevin, C., Descamps, D., Rameix‐Welti, M., Eléouët, J., Goffic, R. L., et al. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14936 · Cited by 54
Metadata
- Authors
- Desforges, M., Le Coupanec, A., Dubeau, P., Bourgouin, A., Lajoie, L., Dubé, M., & Talbot, P. J.
- Affiliations
- Institut National de la Recherche Scientifique (CA)
- Laboratory of Neuroimmunovirology, Institut national de la recherche scientifique (INRS)-Institut Armand-Frappier, Université du Québec, Laval, QC H7V 1B7, Canada
- Université de Sherbrooke (CA)
- Corresponding author
- Desforges, Marc
- Talbot, Pierre J.
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2019-12-20
- Volume
- 12
- Issue
- 1
- Pages
- 14
- ISSN
- 1999-4915 (ISSN-L)
- PMC
- PMC7020001
- OpenAlex
- W2995936855
- Cited by
- 1,048
- References
- 341
- Citations by year
- 2026: 16 · 2025: 32 · 2024: 59 · 2023: 101 · 2022: 200 · 2021: 323 · 2020: 314 · 2019: 3
- FWCI
- 29.51
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Viruses (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- EspaceINRS (National Institute for Scientific Research (Canada)) (submittedVersion)
- HAL (submittedVersion)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
- Funders
- Canadian Institutes of Health Research (MT-9203)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Keywords
- human coronaviruses, respiratory viruses, central nervous system infection, encephalitis, neuropathology, opportunistic pathogens, emerging respiratory viruses, influenza A virus, SARS-CoV, autoimmunity, neurological disorders
- MeSH terms
- Animals, Central Nervous System, Humans, Nervous System Diseases, Respiratory Tract Infections, Virus Replication, Coronavirus, Coronavirus Infections, Encephalitis, Viral, Central Nervous System Viral Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
